TreeWAS – Variant ID: rs2098713

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D86.9 Sarcoidosis, unspecified	0.142	0.858	0.000
D86 Sarcoidosis	0.127	0.873	0.000
D86.0 Sarcoidosis of lung	0.126	0.874	0.000
D86.1 Sarcoidosis of lymph nodes	0.092	0.908	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.087	0.913	0.000
D86.8 Sarcoidosis of other and combined sites	0.086	0.914	0.000
D80-D89 Certain disorders involving the immune mechanism	0.066	0.934	0.000
D86.3 Sarcoidosis of skin	0.061	0.938	0.000
U89.8 Agent resistant to other single specified antibiotic	0.061	0.939	0.000
U89 Agent resistant to other and unspecified antibiotics	0.059	0.941	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.057	0.943	0.000
D84 Other immunodeficiencies	0.055	0.945	0.000
D80 Immunodeficiency with predominantly antibody defects	0.055	0.945	0.000
U88 Agent resistant to multiple antibiotics	0.054	0.946	0.000
D83 Common variable immunodeficiency	0.051	0.949	0.000
Chapter XXII Codes for special purposes	0.048	0.952	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.048	0.952	0.000
U80.0 Penicillin resistant agent	0.048	0.952	0.000
D81 Combined immunodeficiencies	0.047	0.952	0.000
U80 Agent resistant to penicillin and related antibiotics	0.047	0.953	0.000
D84.1 Defects in the complement system	0.046	0.953	0.000
U89.9 Agent resistant to unspecified antibiotic	0.046	0.954	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.046	0.954	0.000
D82 Immunodeficiency associated with other major defects	0.046	0.954	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.044	0.956	0.000
D84.8 Other specified immunodeficiencies	0.043	0.957	0.000
I84.5 External haemorrhoids without complication	0.000	0.957	0.043
U80.8 Agent resistant to other penicillin-related antibiotic	0.042	0.958	0.000
U51 Admission status on psychiatric patients	0.041	0.958	0.000
U84 Resistance to other antimicrobial drugs	0.041	0.959	0.000
U83 Resistance to other antibiotics	0.041	0.959	0.000
U82 Resistance to betalactam antibiotics	0.041	0.959	0.000
U85 Resistance to antineoplastic drugs	0.041	0.959	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.041	0.959	0.000
D83.9 Common variable immunodeficiency, unspecified	0.041	0.959	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.040	0.960	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.039	0.961	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.039	0.961	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.039	0.961	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.039	0.961	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.039	0.961	0.000
D84.9 Immunodeficiency, unspecified	0.039	0.961	0.000
I84 Haemorrhoids	0.000	0.961	0.039
I84.8 Unspecified haemorrhoids with other complications	0.000	0.961	0.039
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.037	0.963	0.000
D83.8 Other common variable immunodeficiencies	0.037	0.963	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.037	0.963	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.037	0.963	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.037	0.963	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.037	0.963	0.000
I84.7 Unspecified thrombosed haemorrhoids	0.000	0.964	0.036
I84.0 Internal thrombosed haemorrhoids	0.000	0.964	0.036
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.035	0.965	0.000
I84.3 External thrombosed haemorrhoids	0.000	0.965	0.035
U50 Level of care administered to neonates	0.035	0.965	0.000
U07 Emergency use of U07	0.035	0.965	0.000
U06 Emergency use of U06	0.035	0.965	0.000
U04 Severe acute respiratory syndrome [SARS]	0.035	0.965	0.000
U52 First in a series of a regular day/night admissions	0.035	0.965	0.000
D81.9 Combined immunodeficiency, unspecified	0.034	0.966	0.000
D81.8 Other combined immunodeficiencies	0.034	0.966	0.000
D81.7 Major histocompatibility complex class II deficiency	0.034	0.966	0.000
D81.6 Major histocompatibility complex class I deficiency	0.034	0.966	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.034	0.966	0.000
D81.4 Nezelof's syndrome	0.034	0.966	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.034	0.966	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.034	0.966	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.034	0.966	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.034	0.966	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.033	0.967	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.033	0.967	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.033	0.967	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.033	0.967	0.000
D82.2 Immunodeficiency with short-limbed stature	0.033	0.967	0.000
D82.0 Wiskott-Aldrich syndrome	0.033	0.967	0.000
D82.1 Di George's syndrome	0.031	0.969	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.030	0.970	0.000
I84.1 Internal haemorrhoids with other complications	0.000	0.970	0.030
U51.2 Previously admitted to a psychiatric hospital of another provider	0.030	0.970	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.030	0.970	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.030	0.970	0.000
U82.8 Resistance to other betalactam antibiotics	0.030	0.970	0.000
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.030	0.970	0.000
U82.1 Resistance to methicillin	0.030	0.970	0.000
U82.0 Resistance to penicillin	0.030	0.970	0.000
U83.9 Resistance to unspecified antibiotic	0.030	0.970	0.000
U83.8 Resistance to other single specified antibiotic	0.030	0.970	0.000
U83.7 Resistance to multiple antibiotics	0.030	0.970	0.000
U83.2 Resistance to quinolones	0.030	0.970	0.000
U83.1 Resistance to other vancomycin related antibiotics	0.030	0.970	0.000
U83.0 Resistance to vancomycin	0.030	0.970	0.000
U84.9 Resistance to unspecified antimicrobial drugs	0.030	0.970	0.000
U84.8 Resistance to other specified antimicrobial drug	0.030	0.970	0.000
U84.7 Resistance to multiple antimicrobial drugs	0.030	0.970	0.000
U84.3 Resistance to tuberculostatic drug(s)	0.030	0.970	0.000
U84.2 Resistance to antiviral drug(s)	0.030	0.970	0.000
U84.1 Resistance to antifungal drug(s)	0.030	0.970	0.000
U84.0 Resistance to antiparasitic drug(s)	0.030	0.970	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.025	0.975	0.000
U06.9 Emergency use of U06.9	0.025	0.975	0.000
U06.8 Emergency use of U06.8	0.025	0.975	0.000
U06.7 Emergency use of U06.7	0.025	0.975	0.000
U06.6 Emergency use of U06.6	0.025	0.975	0.000
U06.5 Emergency use of U06.5	0.025	0.975	0.000
U06.4 Emergency use of U06.4	0.025	0.975	0.000
U06.3 Emergency use of U06.3	0.025	0.975	0.000
U06.2 Emergency use of U06.2	0.025	0.975	0.000
U06.1 Emergency use of U06.1	0.025	0.975	0.000
U06.0 Emergency use of U06.0	0.025	0.975	0.000
U07.9 Emergency use of U07.9	0.025	0.975	0.000
U07.8 Emergency use of U07.8	0.025	0.975	0.000
U07.7 Emergency use of U07.7	0.025	0.975	0.000
U07.6 Emergency use of U07.6	0.025	0.975	0.000
U07.5 Emergency use of U07.5	0.025	0.975	0.000
U07.4 Emergency use of U07.4	0.025	0.975	0.000
U07.3 Emergency use of U07.3	0.025	0.975	0.000
U07.2 Emergency use of U07.2	0.025	0.975	0.000
U07.1 Emergency use of U07.1	0.025	0.975	0.000
U07.0 Emergency use of U07.0	0.025	0.975	0.000
U50.9 Inquest Adjourned Death	0.025	0.975	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.025	0.975	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.025	0.975	0.000
U50.1 Level of care administered to neonates (Special Care)	0.025	0.975	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.025	0.975	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.022	0.978	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.021	0.978	0.000
I84.4 External haemorrhoids with other complications	0.000	0.979	0.021
I84.9 Unspecified haemorrhoids without complication	0.000	0.983	0.017
U81.0 Vancomycin resistant agent	0.017	0.983	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.016	0.984	0.000
D89.3 Immune reconstitution syndrome	0.016	0.984	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.015	0.985	0.000
D89.1 Cryoglobulinaemia	0.013	0.987	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.013	0.987	0.000
E10.3 With ophthalmic complications	0.000	0.988	0.012
E10 Insulin-dependent diabetes mellitus	0.000	0.988	0.012
E10.0 With coma	0.000	0.988	0.012
E10.6 With other specified complications	0.000	0.989	0.011
D89.2 Hypergammaglobulinaemia, unspecified	0.010	0.990	0.000
E10.2 With renal complications	0.000	0.990	0.010
E10.1 With ketoacidosis	0.000	0.990	0.010
F20.0 Paranoid schizophrenia	0.009	0.991	0.000
E10.7 With multiple complications	0.000	0.991	0.009
E10.8 With unspecified complications	0.000	0.991	0.009
I84.2 Internal haemorrhoids without complication	0.000	0.992	0.008
T39.0 Salicylates	0.008	0.992	0.000
U80.1 Methicillin resistant agent	0.008	0.992	0.000
E10.5 With peripheral circulatory complications	0.000	0.992	0.008
F20.9 Schizophrenia, unspecified	0.008	0.992	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.008	0.992	0.000
E10.4 With neurological complications	0.000	0.992	0.008
E11.6 With other specified complications	0.000	0.992	0.008
E10-E14 Diabetes mellitus	0.000	0.992	0.008
D69.6 Thrombocytopenia, unspecified	0.008	0.992	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.008	0.992	0.000
F20 Schizophrenia	0.008	0.992	0.000
E11.3 With ophthalmic complications	0.000	0.993	0.007
T40.4 Other synthetic narcotics	0.007	0.993	0.000
E11 Non-insulin-dependent diabetes mellitus	0.000	0.993	0.007
E10.9 Without complications	0.000	0.993	0.007
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.007	0.993	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.007	0.993	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.007	0.993	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.007	0.993	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.993	0.000
Z22.3 Carrier of other specified bacterial diseases	0.000	0.994	0.006
E11.5 With peripheral circulatory complications	0.000	0.994	0.006
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
S00.0 Superficial injury of scalp	0.006	0.994	0.000
E11.8 With unspecified complications	0.000	0.994	0.006
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
E14 Unspecified diabetes mellitus	0.000	0.994	0.006
T40.6 Other and unspecified narcotics	0.006	0.994	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
T40.3 Methadone	0.006	0.994	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.994	0.006
O69.2 Labour and delivery complicated by other cord entanglement	0.006	0.994	0.000
H02.1 Ectropion of eyelid	0.000	0.994	0.006
F20.8 Other schizophrenia	0.006	0.994	0.000
F20.6 Simple schizophrenia	0.006	0.994	0.000
F20.4 Postschizophrenic depression	0.006	0.994	0.000
F20.3 Undifferentiated schizophrenia	0.006	0.994	0.000
F20.2 Catatonic schizophrenia	0.006	0.994	0.000
F20.1 Hebephrenic schizophrenia	0.006	0.994	0.000
S00.5 Superficial injury of lip and oral cavity	0.006	0.994	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.006	0.994	0.000
T43.6 Psychostimulants with abuse potential	0.006	0.994	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.005	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.994	0.000
E11.7 With multiple complications	0.000	0.994	0.005
F20.5 Residual schizophrenia	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
I84.6 Residual haemorrhoidal skin tags	0.000	0.995	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
E11.4 With neurological complications	0.000	0.995	0.005
E14.3 With ophthalmic complications	0.000	0.995	0.005
T50.8 Diagnostic agents	0.005	0.995	0.000
R61.9 Hyperhidrosis, unspecified	0.000	0.995	0.005
E14.2 Withrenal complications	0.000	0.995	0.005
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.005	0.995	0.000
T40.8 Lysergide [LSD]	0.005	0.995	0.000
T40.7 Cannabis (derivatives)	0.005	0.995	0.000
T40.0 Opium	0.005	0.995	0.000
T47.0 Histamine H(2)-receptor antagonists	0.005	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.005	0.995	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.005	0.995	0.000
D69 Purpura and other haemorrhagic conditions	0.005	0.995	0.000
E14.6 With other specified complications	0.000	0.995	0.005
T40.1 Heroin	0.005	0.995	0.000
T40.5 Cocaine	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
E14.5 With peripheral circulatory complications	0.000	0.995	0.005
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.005	0.995	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
T44.0 Anticholinesterase agents	0.005	0.995	0.000
E13 Other specified diabetes mellitus	0.000	0.995	0.005
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
T47.7 Emetics	0.005	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.005	0.995	0.000
T47.5 Digestants	0.005	0.995	0.000
T47.4 Other laxatives	0.005	0.995	0.000
T47.3 Saline and osmotic laxatives	0.005	0.995	0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.000	0.995	0.005
K22.4 Dyskinesia of oesophagus	0.005	0.995	0.000
E14.4 With neurological complications	0.000	0.995	0.005
E11.2 With renal complications	0.000	0.995	0.005
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
T43.9 Psychotropic drug, unspecified	0.005	0.995	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
E14.7 With multiple complications	0.000	0.995	0.005
E14.0 With coma	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.004	0.995	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.995	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.995	0.000
D69.2 Other nonthrombocytopenic purpura	0.004	0.995	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
E12.9 Without complications	0.000	0.996	0.004
E12.8 With unspecified complications	0.000	0.996	0.004
E12.7 With multiple complications	0.000	0.996	0.004
E12.6 With other specified complications	0.000	0.996	0.004
E12.5 With peripheral circulatory complications	0.000	0.996	0.004
E12.4 With neurological complications	0.000	0.996	0.004
E12.3 With ophthalmic complications	0.000	0.996	0.004
E12.2 With renal complications	0.000	0.996	0.004
E12.1 With ketoacidosis	0.000	0.996	0.004
E12.0 With coma	0.000	0.996	0.004
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
S00 Superficial injury of head	0.004	0.996	0.000
S00.1 Contusion of eyelid and periocular area	0.004	0.996	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
T42.4 Benzodiazepines	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
T48.4 Expectorants	0.004	0.996	0.000
T48.3 Antitussives	0.004	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
T48.0 Oxytocic drugs	0.004	0.996	0.000
I08.0 Disorders of both mitral and aortic valves	0.004	0.996	0.000
D69.4 Other primary thrombocytopenia	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
S00.4 Superficial injury of ear	0.004	0.996	0.000
T41.5 Therapeutic gases	0.004	0.996	0.000
T41.4 Anaesthetic, unspecified	0.004	0.996	0.000
T41.3 Local anaesthetics	0.004	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
T41.1 Intravenous anaesthetics	0.004	0.996	0.000
T41.0 Inhaled anaesthetics	0.004	0.996	0.000
T49.9 Topical agent, unspecified	0.004	0.996	0.000
T49.8 Other topical agents	0.004	0.996	0.000
T49.7 Dental drugs, topically applied	0.004	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.996	0.000
T49.2 Local astringents and local detergents	0.004	0.996	0.000
T49.1 Antipruritics	0.004	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
D69.8 Other specified haemorrhagic conditions	0.004	0.996	0.000
D69.1 Qualitative platelet defects	0.004	0.996	0.000
E14.8 With unspecified complications	0.000	0.996	0.004
T42.0 Hydantoin derivatives	0.004	0.996	0.000
D69.9 Haemorrhagic condition, unspecified	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
D69.0 Allergic purpura	0.004	0.996	0.000
E11.1 With ketoacidosis	0.000	0.996	0.004
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
E13.8 With unspecified complications	0.000	0.996	0.004
E13.7 With multiple complications	0.000	0.996	0.004
E13.6 With other specified complications	0.000	0.996	0.004
E13.5 With peripheral circulatory complications	0.000	0.996	0.004
E13.4 With neurological complications	0.000	0.996	0.004
E13.2 With renal complications	0.000	0.996	0.004
E13.1 With ketoacidosis	0.000	0.996	0.004
E13.0 With coma	0.000	0.996	0.004
E13.3 With ophthalmic complications	0.000	0.996	0.004
E14.1 With ketoacidosis	0.000	0.996	0.004
T42.1 Iminostilbenes	0.004	0.996	0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.004	0.996	0.000
M62.81 Other specified disorders of muscle (Shoulder region)	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.003	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.996	0.000
S00.3 Superficial injury of nose	0.003	0.997	0.000
E11.0 With coma	0.000	0.997	0.003
O69.8 Labour and delivery complicated by other cord complications	0.003	0.997	0.000
D69.5 Secondary thrombocytopenia	0.003	0.997	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
D67 Hereditary factor IX deficiency	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
H02.5 Other disorders affecting eyelid function	0.000	0.997	0.003
N90.7 Vulvar cyst	0.003	0.997	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Z22 Carrier of infectious disease	0.000	0.997	0.003
H36.0 Diabetic retinopathy	0.000	0.997	0.003
E14.9 Without complications	0.000	0.997	0.003
O69 Labour and delivery complicated by umbilical cord complications	0.003	0.997	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.003	0.997	0.000
Z90.8 Acquired absence of other organs	0.000	0.997	0.003
D23.6 Skin of upper limb, including shoulder	0.000	0.997	0.003
T40.2 Other opioids	0.003	0.997	0.000
E13.9 Without complications	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
S00.2 Other superficial injuries of eyelid and periocular area	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
D55-D59 Haemolytic anaemias	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
T38.7 Androgens and anabolic congeners	0.002	0.997	0.000
T38.5 Other oestrogens and progestogens	0.002	0.997	0.000
T38.4 Oral contraceptives	0.002	0.997	0.000
T38.2 Antithyroid drugs	0.002	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.997	0.000
M62.8 Other specified disorders of muscle	0.003	0.997	0.000
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts	0.000	0.997	0.003
Z22.8 Carrier of other infectious diseases	0.000	0.997	0.003
M62.80 Other specified disorders of muscle (Multiple sites)	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.997	0.003
M62.89 Other specified disorders of muscle (Site unspecified)	0.003	0.997	0.000
J33.8 Other polyp of sinus	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
T45.5 Anticoagulants	0.002	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
S82.00 Fracture of patella (closed)	0.000	0.997	0.003
Z22.9 Carrier of infectious disease, unspecified	0.000	0.997	0.002
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.997	0.002
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.997	0.002
Z22.2 Carrier of diphtheria	0.000	0.997	0.002
Z22.0 Carrier of typhoid	0.000	0.997	0.002
F60.3 Emotionally unstable personality disorder	0.003	0.997	0.000
O69.5 Labour and delivery complicated by vascular lesion of cord	0.002	0.997	0.000
O69.4 Labour and delivery complicated by vasa praevia	0.002	0.997	0.000
O69.3 Labour and delivery complicated by short cord	0.002	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.997	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
E80.4 Gilbert's syndrome	0.002	0.998	0.000
O69.9 Labour and delivery complicated by cord complication, unspecified	0.002	0.998	0.000
R61 Hyperhidrosis	0.000	0.998	0.002
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.998	0.002
S00.7 Multiple superficial injuries of head	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.001
D55 Anaemia due to enzyme disorders	0.002	0.998	0.000
M62.82 Other specified disorders of muscle (Upper arm)	0.002	0.998	0.000
D66 Hereditary factor VIII deficiency	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
D57 Sickle-cell disorders	0.002	0.998	0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.002	0.998	0.000
D56 Thalassaemia	0.002	0.998	0.000
M62.87 Other specified disorders of muscle (Ankle and foot)	0.002	0.998	0.000
O69.0 Labour and delivery complicated by prolapse of cord	0.002	0.998	0.000
C44.7 Skin of lower limb, including hip	0.000	0.998	0.002
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
M62.88 Other specified disorders of muscle (Other)	0.002	0.998	0.000
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.998	0.002
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.002	0.998	0.000
B35.3 Tinea pedis	0.000	0.998	0.002
M62.83 Other specified disorders of muscle (Forearm)	0.002	0.998	0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.000	0.998	0.002
M62.84 Other specified disorders of muscle (Hand)	0.002	0.998	0.000
D73.5 Infarction of spleen	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
M84.48 Pathological fracture, not elsewhere classified (Other)	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.998	0.002
J39.8 Other specified diseases of upper respiratory tract	0.000	0.998	0.002
D39.1 Ovary	0.002	0.998	0.000
C16.0 Cardia	0.000	0.998	0.002
D59 Acquired haemolytic anaemia	0.002	0.998	0.000
D50-D53 Nutritional anaemias	0.002	0.998	0.000
R61.0 Localised hyperhidrosis	0.000	0.998	0.002
D58 Other hereditary haemolytic anaemias	0.002	0.998	0.000
D52.9 Folate deficiency anaemia, unspecified	0.002	0.998	0.000
R61.1 Generalised hyperhidrosis	0.000	0.998	0.002
M89.90 Disorder of bone, unspecified (Multiple sites)	0.002	0.998	0.000
A04.5 Campylobacter enteritis	0.002	0.998	0.000
B35.1 Tinea unguium	0.000	0.998	0.002
D52 Folate deficiency anaemia	0.002	0.998	0.000
D55.9 Anaemia due to enzyme disorder, unspecified	0.002	0.998	0.000
D55.8 Other anaemias due to enzyme disorders	0.002	0.998	0.000
D55.3 Anaemia due to disorders of nucleotide metabolism	0.002	0.998	0.000
D55.2 Anaemia due to disorders of glycolytic enzymes	0.002	0.998	0.000
D55.1 Anaemia due to other disorders of glutathione metabolism	0.002	0.998	0.000
D55.0 Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency	0.002	0.998	0.000
T14.0 Superficial injury of unspecified body region	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.001	0.998	0.001
Y00.9 Unspecified place	0.000	0.998	0.002
D57.8 Other sickle-cell disorders	0.002	0.998	0.000
D57.3 Sickle-cell trait	0.002	0.998	0.000
D57.2 Double heterozygous sickling disorders	0.002	0.998	0.000
D57.0 Sickle-cell anaemia with crisis	0.002	0.998	0.000
D56.9 Thalassaemia, unspecified	0.002	0.998	0.000
D56.8 Other thalassaemias	0.002	0.998	0.000
D56.4 Hereditary persistence of foetal haemoglobin [HPFH]	0.002	0.998	0.000
D56.2 Delta-beta thalassaemia	0.002	0.998	0.000
D56.0 Alpha thalassaemia	0.002	0.998	0.000
D56.3 Thalassaemia trait	0.002	0.998	0.000
D57.1 Sickle-cell anaemia without crisis	0.002	0.998	0.000
G31.8 Other specified degenerative diseases of nervous system	0.002	0.998	0.000
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.000	0.998	0.002
D56.1 Beta thalassaemia	0.002	0.998	0.000
Z57.2 Occupational exposure to dust	0.002	0.998	0.000
Z73.9 Problem related to life-management difficulty, unspecified	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.001
F06.7 Mild cognitive disorder	0.002	0.998	0.000
B35 Dermatophytosis	0.000	0.998	0.002
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.002	0.998	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.002	0.998	0.000
C90.0 Multiple myeloma	0.000	0.998	0.002
D59.4 Other nonautoimmune haemolytic anaemias	0.002	0.998	0.000
A07.1 Giardiasis [lambliasis]	0.002	0.998	0.000
K62.6 Ulcer of anus and rectum	0.000	0.998	0.002
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.002	0.998	0.000
B44.1 Other pulmonary aspergillosis	0.000	0.998	0.002
D73 Diseases of spleen	0.002	0.998	0.000
D59.8 Other acquired haemolytic anaemias	0.001	0.998	0.000
D59.6 Haemoglobinuria due to haemolysis from other external causes	0.001	0.998	0.000
D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]	0.001	0.998	0.000
D59.3 Haemolytic-uraemic syndrome	0.001	0.998	0.000
D59.2 Drug-induced nonautoimmune haemolytic anaemia	0.001	0.998	0.000
D59.0 Drug-induced autoimmune haemolytic anaemia	0.001	0.998	0.000
D73.4 Cyst of spleen	0.002	0.998	0.000
Z73.8 Other problems related to life-management difficulty	0.000	0.998	0.002
D58.8 Other specified hereditary haemolytic anaemias	0.001	0.998	0.000
D58.2 Other haemoglobinopathies	0.001	0.998	0.000
D58.1 Hereditary elliptocytosis	0.001	0.998	0.000
D52.8 Other folate deficiency anaemias	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations